Healthcare Stocks on the Rise: Capitalizing on Medicare Reforms

Are you looking to take advantage of the growing opportunities in the healthcare sector? Markets are once again focusing on healthcare stocks following recent pledges by politicians to expand Medicare funding in Australia. The Australian government and opposition have unveiled substantial plans to improve access to healthcare services for all Australians.

These reforms promise that bulk-billed services will expand, providing more care and lower costs for health services, mental health services, and general practice. As these changes take shape, healthcare-related stocks are expected to emerge as winners, making this an exciting topic for investors. Let’s dive into how these Medicare reforms could impact the market and investment opportunities.

 

Considerations for Investors

The increase in funding for Medicare will create growth opportunities for healthcare companies. However, investors should note that financial benefits may be influenced by a broader regulatory and market environment. For instance, the Justice Department recently investigated the billing practices of UnitedHealth Group’s Medicare program, highlighting the importance of due diligence.

Market dynamics can also be affected by discussions around possible cuts to Medicare Advantage and other policy modelling. While some aspects may be overhyped, analysts recommend staying informed about policy developments as part of making informed investment decisions.

 

Opposition’s $9 Billion Counterproposal

Opposition Leader Peter Dutton has proposed a $9 billion boost to Medicare in response, which is $500 million more than the government’s plan. This includes a previously announced $500 million to bulk-bill mental health appointments.

The opposition’s strategy aims to restore bulk billing rates to former levels and address what it calls a healthcare crisis. Dutton has urged the government to improve its handling of healthcare by providing greater access to bulk-billed services.

 

Government’s $8.5 Billion Medicare Investment

Prime Minister Anthony Albanese has announced an $8.5 billion Medicare investment, marking the largest investment since the health scheme began 40 years ago. The goal is to make nine out of ten GP visits bulk-billed by 2030, delivering an additional 18 million GP visits per year.

The plan includes over 400 nursing scholarships by 2028 and the training of 2,000 new GP trainees annually. Bulk billing already applies to all patients receiving pharmaceutical services under the Pharmaceutical Benefits Scheme (PBS). Additionally, the government aims to eliminate out-of-pocket costs for patients by extending bulk-billing incentives to all Medicare cardholders, valued at up to $859 million per year by 2030.

 

Current Performance of Healthcare Stocks

As of February 27, 2025, several healthcare-related stocks have shown varied performance:

• Health Care Select Sector SPDR (XLV): Trading at $147.82, a slight decrease of 0.68% from the previous close.
• Vanguard Health Care ETF (VHT): Priced at $270.45, down 0.63%.
• iShares U.S. Medical Devices ETF (IHI): At $64.26, reflecting a modest increase of 0.49%.
• Johnson & Johnson (JNJ): Trading at $163.08, a decrease of 1.82%.
• Pfizer Inc. (PFE): Priced at $26.42, down 1.20%.
• UnitedHealth Group Inc (UNH): At $463.59, a decline of 1.41%.
• CVS Health Corp (CVS): Trading at $63.86, a slight increase of 0.35%.
• Humana Inc. (HUM): Priced at $255.07, down 1.64%.
• Cigna Group (CI): At $305.34, a decrease of 2.72%.

 

Implications for Healthcare Stocks

Medicare funding pledges made in recent days will affect the stock of healthcare-related companies. In the case of the healthcare sector, there is a rise in demand for their services and products. The following key factors should be considered by investors when looking at this evolving landscape:

Increased Patient Volume

By increasing bulk-billed services, more Australians will be able to receive medical care. Such a surge in patient numbers could be good for hospitals, clinics, and healthcare service providers. In such a situation, companies providing consultations, diagnostic tests, or treatments will realise more revenues.

Expansion of Services

Mental health services and healthcare training programmes are included in the new funding. It could fund the development of new facilities, specialised treatments, and increased professionally trained staff. This may help healthcare companies to expand their offerings, generating extra revenue and streamlining service access.

Policy Stability

The long-term policy stability of dedicated money spent for Medicare has been committed to by both major political parties. Uncertainty is reduced under a predictable regulatory environment, which is an incentive for investors. For the sector, companies can plan long-term strategies while investors can expect steady growth in healthcare-related stocks.

 

Conclusion

The government and the opposition’s recent renewed commitments to pay for Medicare represent a large shift in the health care services offered in Australia. They aim to increase access to medical services, reduce out-of-pocket expenses for patients, and improve the overall healthcare infrastructure. These developments offer proponents in the healthcare sector to investors.

Now, it is important to do your research well and always take into account the bigger picture of the regulatory landscape when making any kind of investment. Investors are better able to capitalise on the evolving healthcare market once they stay informed and can evaluate the potential impacts of policy changes.

 

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips